Amarin reported $393K in Interest Expense on Debt for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Adamas Pharmaceuticals ADMS:US 3.5M 28K
Aerie Pharmaceuticals AERI:US $ 7.36M 0.24M
Alnylam Pharmaceuticals ALNY:US $ 40.27M 6.86M
Amarin AMRN:US $ 0.39M 0.36M
Arena Pharmaceuticals ARNA:US $ 1.03M 0.02M
Biocryst Pharmaceuticals BCRX:US $ 14.12M 0.62M
Epizyme EPZM:US $ 445K 52K
Esperion Therapeutics ESPR:US $ 13.65M 2.51M
Halozyme Therapeutics HALO:US $ 1.75M 0M
Intercept Pharmaceuticals ICPT:US $ 14.1M 1.51M
JAZZ PHA JAZZ:US $ 93.47M 23.65M
Nektar Therapeutics NKTR:US $ 12.8M 0.29M
Neurocrine Biosciences NBIX:US $ 6.6M 0.4M
Novartis NOVN:VX 202M 1000K
Teva Pharmaceutical Industries TEVA:US $ 232M 8M